E9D-15286-76877
4 vaccinations
8 coded responses
44 check-ins
8 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 606 / IL
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ZL2-52944-51574
Child or adolescent in my care · Male · 2022-06-29
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2020-12-19
- 2020-12-20
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Headache, Fatigue or tirednessFree text: Large painful axillary lymph node on side of injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Site: Pain · HeadacheFree text: Painful axillary lymph node on side of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
-
2021-07-08
Survey response — 6 months, dose 2MedDRA: Dyspnoea — Feeling: GoodFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-02
Dose 3 — Pfizer-BioNTech
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Enlarged and painful axillary lymph node on the side the vaccine was givenMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-10-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Painful enlarged axillary lymphnode on the side the vaccine was givenMedDRA releases: 2024-11 · check-in free text available
-
2021-10-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
-
2022-01-01
Survey response — 3 months, dose 3MedDRA: COVID-19, Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: I have COVID now. It is very mild. Runny nose, mildly sore throat, mild headache. I believe the vaccine is the reason I have only mild symptoms!MedDRA releases: 2024-11 · check-in free text available
- 2022-04-02
- 2022-10-02
-
2022-10-08
Dose 4 — Moderna
-
2022-10-18
Survey response — day 7, dose 4MedDRA: Arthralgia, Chills, Headache, Injection site erythema, Injection site oedema, Injection site warmth, Myalgia, Pyrexia — Feeling: GoodFree text: Today, I had none of these symptoms. Beginning 12 hours after injection and continuing for 48 hours after that, I had fever, chills, headache, arthralgias, myalgias. For 7 days after injection I had injection site erythema, edema, and warmth and axilMedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
-
2022-10-31
Survey response — day 21, dose 4MedDRA: Oropharyngeal pain, Rhinorrhoea — Feeling: GoodFree text: Rhinorrhea, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-11-06
- 2022-11-14
- 2022-11-19
- 2023-01-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-10-08 | Moderna | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Large painful axillary lymph node on side of injection arm
Systemic reaction (other): Painful axillary lymph node on side of injection
Release 9 — 6 months, dose 2
Symptoms: Shortness of breath
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Enlarged and painful axillary lymph node on the side the vaccine was given
Systemic reaction (other): Painful enlarged axillary lymphnode on the side the vaccine was given
Release 10 — 3 months, dose 3
Symptoms: I have COVID now. It is very mild. Runny nose, mildly sore throat, mild headache. I believe the vaccine is the reason I have only mild symptoms!
Release 12 — day 7, dose 4
Systemic reaction (other): Today, I had none of these symptoms. Beginning 12 hours after injection and continuing for 48 hours after that, I had fever, chills, headache, arthralgias, myalgias. For 7 days after injection I had injection site erythema, edema, and warmth and axil cut off by CDC
Release 12 — day 21, dose 4
Symptoms: Rhinorrhea, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Arthralgia | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site oedema | · | · | ✓ |
| SRO | Injection site warmth | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Myalgia | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release